Turkey Pharmas Complain To Govt About Lira Devaluation Impact
This article was originally published in PharmAsia News
Executive Summary
Turkey drug makers complain their nation’s move to allow increased drug prices at the same time the value-added tax on pharmaceuticals is lowered did nothing to resolve their losses resulting from the lira devaluation vis a vis the euro and U.S. dollar.